OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases
George El-Arif, Shaymaa Khazaal, Antonella Farhat, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2048-2048
Open Access | Times Cited: 71
George El-Arif, Shaymaa Khazaal, Antonella Farhat, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2048-2048
Open Access | Times Cited: 71
Showing 26-50 of 71 citing articles:
Anti-COVID-19 Vaccination, COVID-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill
Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 5
Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 5
Understanding and Relieving of Neuropathic Disorders in the Long COVID
Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 5
Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 4
Closed Access | Times Cited: 5
Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming
Liangzhi Chen, Ping Gong, Yue Su, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 99-108
Closed Access | Times Cited: 5
Liangzhi Chen, Ping Gong, Yue Su, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 99-108
Closed Access | Times Cited: 5
Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination
Alan K. Chang, Yung–Ming Jeng, Cheng‐Maw Ho, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Alan K. Chang, Yung–Ming Jeng, Cheng‐Maw Ho, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Marine sourced tripeptide SRP and its sustained-release formulation SRP-PLGA-MS exhibiting antihypertensive effect in spontaneously hypertensive rats and HUVECs
Miaoen Huang, Tianji Wang, Yinghao Wang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Miaoen Huang, Tianji Wang, Yinghao Wang, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 1
Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection
Nurshamimi Nor Rashid, Lina Amrani, A F Alwan, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 1
Nurshamimi Nor Rashid, Lina Amrani, A F Alwan, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 1
Effect of COVID-19 infection on thyroid function status and clinical indexes among hypothyroid outpatients
Bingxin Li, Xiaoyun Feng, Yihan Zhang, et al.
Virulence (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Bingxin Li, Xiaoyun Feng, Yihan Zhang, et al.
Virulence (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Protein nanoparticle-induced osmotic pressure gradients modify pulmonary edema through hyperpermeability in acute respiratory distress syndrome
Qian Zhizhi, QianYi Wang, Zhaoshun Qiu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Qian Zhizhi, QianYi Wang, Zhaoshun Qiu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 8
The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations
Minela Aida Mărănducă, Calin George Vamesu, Daniela Maria Tănase, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 8
Minela Aida Mărănducă, Calin George Vamesu, Daniela Maria Tănase, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1717-1717
Open Access | Times Cited: 8
Causal influences of osteoarthritis on COVID-19: a Mendelian randomization study
Li Fu, Ancha Baranova, Hongbao Cao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Li Fu, Ancha Baranova, Hongbao Cao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
Randy Felber, William New, Suzanne I Riskin
Cureus (2024)
Open Access | Times Cited: 1
Randy Felber, William New, Suzanne I Riskin
Cureus (2024)
Open Access | Times Cited: 1
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function
Juan Fernando Padín, José Manuel Pérez‐Ortiz, Francisco Javier Redondo Calvo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7553-7553
Open Access | Times Cited: 1
Juan Fernando Padín, José Manuel Pérez‐Ortiz, Francisco Javier Redondo Calvo
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7553-7553
Open Access | Times Cited: 1
Aldosterone as a Possible Contributor to Eye Diseases
Tomomi Higashide, Kazuyuki Hirooka, Mitsuhiro Kometani, et al.
Endocrinology (2022) Vol. 164, Iss. 2
Closed Access | Times Cited: 6
Tomomi Higashide, Kazuyuki Hirooka, Mitsuhiro Kometani, et al.
Endocrinology (2022) Vol. 164, Iss. 2
Closed Access | Times Cited: 6
COVID-19 and Alzheimer's Disease: The Link Finally Established
Ziad Fajloun, Yingliang Wu, Zhijian Cao, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 7
Closed Access | Times Cited: 3
Ziad Fajloun, Yingliang Wu, Zhijian Cao, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 7
Closed Access | Times Cited: 3
COVID-19 and Parkinson's Disease: The Link also Established!
Ziad Fajloun, Yingliang Wu, Zhijian Cao, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 8
Closed Access | Times Cited: 3
Ziad Fajloun, Yingliang Wu, Zhijian Cao, et al.
Infectious Disorders - Drug Targets (2023) Vol. 23, Iss. 8
Closed Access | Times Cited: 3
Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients
Bong Soo Son, Hyun Ji Lee, Woo Hyun Cho, et al.
Transplant Immunology (2023) Vol. 80, pp. 101901-101901
Closed Access | Times Cited: 3
Bong Soo Son, Hyun Ji Lee, Woo Hyun Cho, et al.
Transplant Immunology (2023) Vol. 80, pp. 101901-101901
Closed Access | Times Cited: 3
The risk factors of postoperative hypoxemia in patients with Stanford type A acute aortic dissection
Xu’an Wang, Jun Ma, Duomao Lin, et al.
Medicine (2023) Vol. 102, Iss. 33, pp. e34704-e34704
Open Access | Times Cited: 3
Xu’an Wang, Jun Ma, Duomao Lin, et al.
Medicine (2023) Vol. 102, Iss. 33, pp. e34704-e34704
Open Access | Times Cited: 3
The Unsuspected Role of the Renin-Angiotensin System (RAS): Could its Dysregulation be at the Root of All Non-Genetic Human Diseases?
Ziad Fajloun, Jean‐Marc Sabatier
Infectious Disorders - Drug Targets (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 3
Ziad Fajloun, Jean‐Marc Sabatier
Infectious Disorders - Drug Targets (2023) Vol. 24, Iss. 1
Closed Access | Times Cited: 3
Transcriptional Profiling of SARS-CoV-2-Infected Calu-3 Cells Reveals Immune-Related Signaling Pathways
Eric Petterson Viana Pereira, Stela Mirla da Silva Felipe, Raquel Martins de Freitas, et al.
Pathogens (2023) Vol. 12, Iss. 11, pp. 1373-1373
Open Access | Times Cited: 3
Eric Petterson Viana Pereira, Stela Mirla da Silva Felipe, Raquel Martins de Freitas, et al.
Pathogens (2023) Vol. 12, Iss. 11, pp. 1373-1373
Open Access | Times Cited: 3
COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment
Ioannis Liapis, Stavroula Baritaki
Cancers (2022) Vol. 14, Iss. 17, pp. 4330-4330
Open Access | Times Cited: 5
Ioannis Liapis, Stavroula Baritaki
Cancers (2022) Vol. 14, Iss. 17, pp. 4330-4330
Open Access | Times Cited: 5
A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth muscle relaxant effects of Paulownia tomentosa Steud
Fabio Magurano, Matteo Micucci, Domenico Nuzzo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114083-114083
Open Access | Times Cited: 5
Fabio Magurano, Matteo Micucci, Domenico Nuzzo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114083-114083
Open Access | Times Cited: 5
Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play
Patrick Chambers
(2024)
Open Access
Patrick Chambers
(2024)
Open Access
Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play
Patrick Chambers
Qeios (2024)
Open Access
Patrick Chambers
Qeios (2024)
Open Access
Staunch the Age Related Decline into Dementia, Cancer, Autoimmunity (Long Covid), Obesity, and Other Diseases with a Prebiotic, Probiotic, Postbiotic Triple Play
Patrick Chambers
Qeios (2024)
Open Access
Patrick Chambers
Qeios (2024)
Open Access
The predictive power of data: machine learning analysis for Covid-19 mortality based on personal, clinical, preclinical, and laboratory variables in a case–control study
Maryam Seyedtabib, Roya Najafi‐Vosough, Naser Kamyari
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Maryam Seyedtabib, Roya Najafi‐Vosough, Naser Kamyari
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
